Cephalon announces receipt of a Paragraph IV Certification Notice Letter regarding ANDA Cephalon.

Teva’s Notice Letter does not challenge Orange Book-shown U.S. Patent No. 4,927,855 , until October 22 which provides additional protection, 2010, the expiration day of the ‘855 Patent.. Cephalon announces receipt of a Paragraph IV Certification Notice Letter regarding ANDA Cephalon, Inc. today announced receipt of a Paragraph IV Qualification Notice Letter on October 20, 2009 relating to an Abbreviated New Drug Software submitted to the U.S.Over the next several years, we plan to enhance our capabilities through both item acquisitions and extensions. We believe that execution of this strategy will advance our position as the market innovator in endotoxin and microbial recognition. Â Â Â Â.. CDC recommends seasonal influenza vaccination to counter H1N1 Public health experts, including the Centers for Disease Control and Prevention , recommend seasonal influenza vaccination while the first type of defense this complete year in avoiding the influenza virus. The American Lung Association of the Central Says is normally kicking off its 2009-2010 Faces of Influenza initiative in Kansas City and is supporting local public health efforts to get Greater Kansas City Metro area occupants vaccinated against seasonal influenza as soon as possible.

Other Posts From "reports":

Related Posts